Analyst firms · Needham · COLL
Needham COLL price target and rating history
Collegium Pharmaceutical Inc. (COLL) · Health Care
Needham rates Collegium Pharmaceutical Inc. (COLL) Buy with a $46 price target, as of its latest action on Jan 10, 2025. It has published 7 rating actions on COLL since August 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.
- Current rating
- Buy
- Price target
- $46
- Median target, all firms
- $49.50
- Actions on COLL
- 7
Needham price target on COLL
Every Needham rating on COLL
- Jan 10, 2025
- May 10, 2024DowngradeNeedham downgrades to Hold from Buy
- Aug 25, 2023
- Feb 15, 2022
- Nov 15, 2021
- Nov 5, 2021
- Aug 6, 2021
How other firms rate COLL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Oppenheimer | Outperform | $50 | Sep 23, 2026 |
| Truist Securities | Buy | $49 | Sep 9, 2026 |
| Leerink Partners | Outperform | $45 | Sep 9, 2026 |
| Barclays | Overweight | $58 | Dec 9, 2025 |
Questions about Needham and COLL
- What is Needham's price target for COLL?
- Needham's latest stated price target for Collegium Pharmaceutical Inc. (COLL) is $46, from its action on Jan 10, 2025.
- What is Needham's rating on COLL?
- Needham rates COLL Buy, a bullish rating, as of Jan 10, 2025.
- When did Needham last change its view on COLL?
- On Jan 10, 2025, Needham upgrades to Buy from Hold, price target $46.
- How does Needham's COLL target compare with other analysts?
- Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.
More COLL rating histories
All Needham ratingsCOLL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.